CIK 0001479615 · Non-accelerated filer<br>Smaller reporting company
Silence Therapeutics plc
Sign in to watch- Tickers
- SLN SLNCF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44-0-20-3457 6900
- Business address
- 12 HAMMERSMITH GROVE, OFFICE 205, LONDON, United Kingdom, W6 7AP
Securities
- SLN American Depository Share Nasdaq
- SLNCF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-27 | Griffiths Richard Ian 10% owner | Purchase · American Depositary Shares | +50,000 | 9,611,299 | ||
| 2025-03-05 | Griffiths Richard Ian 10% owner | Purchase · American Depositary Shares | +22,632 | 9,561,299 | ||
| 2025-02-18 | Griffiths Richard Ian 10% owner | Purchase · American Depositary Shares | +60,000 | 9,538,667 | ||
| 2025-02-13 | Griffiths Richard Ian 10% owner | Purchase · American Depositary Shares | +92,774 | 9,418,667 | ||
| 2025-02-13 | Griffiths Richard Ian 10% owner | Purchase · American Depositary Shares | +60,000 | 9,478,667 | ||
| 2025-01-23 | Griffiths Richard Ian 10% owner | Purchase · American Depositary Shares | +12,226 | 9,325,893 | ||
| 2025-01-21 | Griffiths Richard Ian 10% owner | Purchase · American Depositary Shares | +25,000 | 9,293,667 | ||
| 2025-01-21 | Griffiths Richard Ian 10% owner | Purchase · American Depositary Shares | +20,000 | 9,313,667 | ||
| 2025-01-17 | Griffiths Richard Ian 10% owner | Purchase · American Depositary Shares | +150,000 | 9,268,667 | ||
| 2025-01-08 | Griffiths Richard Ian 10% owner | Purchase · American Depositary Shares | +30,000 | 9,118,667 | ||
| 2025-01-02 | Davidson Michael H. Director | Grant or award · Share Option (Right to Buy) | +48,000 | 48,000 | ||
| 2025-01-02 | Ede-Golightly James Director | Grant or award · Share Option (Right to Buy) | +48,000 | 48,000 | ||
| 2025-01-02 | Ross Iain Director | Grant or award · Share Option (Right to Buy) | +90,000 | 90,000 | ||
| 2025-01-02 | Lemus David Director | Grant or award · Share Option (Right to Buy) | +48,000 | 48,000 | ||
| 2025-01-02 | Romano Steven J. EVP and Chief R&D Officer | Grant or award · Employee Share Option (Right to Buy) | +285,000 | 285,000 | ||
| 2025-01-02 | HELLUMS RHONDA LYNETTE Chief Financial Officer | Grant or award · Employee Share Option (Right to Buy) | +375,000 | 375,000 | ||
| 2025-01-02 | TOOMAN CRAIG A President and CEO | Grant or award · Employee Share Option (Right to Buy) | +900,000 | 900,000 |
Page 5 of 5 · 97 trades